1 For a performance comparison as of the most recent month-end click here. Performance data quoted represents past performance. Investment return and principal will fluctuate, so that shares, when redeemed, may be worth more or less than their original cost. Past performance is no guarantee of future results. Current performance may be lower or higher than the performance information quoted. A Fund's performance, especially for short time periods, should not be the sole factor in making an investment decision.
Please consider the Fund's investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus, which contains this and other information about the Fund, click here or call 888-860-8686. Please read the prospectus carefully before investing.
2The S&P 500 Index is a registered trademark of S&P and is an unmanaged broadly-based index of the common stock prices of 500 large U.S. companies, and includes the reinvestment of dividends. The Russell 1000 Growth Index measures the performance of the large cap growth segment of the largest 1000 U.S. companies, based on total market capitalization, higher price-to-book ratios and higher forecasted growth values, and includes the reinvestment of dividends. The indexes described above are unmanaged and not available for direct investment. For comparison purposes, it should be noted that the indexes described above do not charge fees and have no expenses.
3Source: London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2018. FTSE Russell is a trading name of certain of the LSE Group companies. Russell® is a trade mark of the relevant LSE Group companies and is/are used by any other LSE Group company under license. “TMX®” is a trade mark of TSX, Inc. and used by the LSE Group under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company's express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.
4Lipper Inc., A Refinitiv Company, is a nationally recognized organization that measures the performance of mutual funds within a universe of funds that have similar investment objectives. Returns are historical with capital gains and dividends reinvested. The Lipper Large-Cap Growth Index is an unmanaged index that, by portfolio practice, invests at least 75% of its equity assets in companies with market capitalizations (on a three-year basis) above Lipper's USDE large-cap floor.
5As of the Fund's 2/1/2021 prospectus; 1.49% gross, 1.45%
net. Marsico Capital Management, LLC, the investment adviser to the Fund (the
"Adviser"), has entered into a written expense limitation and fee
waiver agreement under which it has agreed to limit the total expenses of the Focus
Fund (excluding taxes, interest, acquired fund fees and expenses, litigation,
extraordinary expenses, and brokerage and other transaction expenses relating
to the purchase or sale of portfolio investments) to an annual rate of 1.45% of
the Fund's average net assets until January 31, 2022. This expense limitation and
fee waiver agreement may be terminated by the Adviser at any time
after January 31, 2022 upon 15 days prior notice to the Fund and its
administrator, provided that no such modification will be made in a manner
inconsistent with the terms of the current prospectus. The Adviser may recoup
from the Fund fees previously waived or expenses previously reimbursed by the
Adviser with respect to the Fund pursuant to this agreement (or a previous
expense limitation agreement) if: (1) such recoupment by the Adviser does not
cause the Fund, at the time of recoupment, to exceed the lesser of (a) the
expense limitation in effect at the time the relevant amount was waived and/or
reimbursed, or (b) the expense limitation in effect at the time of the proposed
recoupment, and (2) the recoupment is made within three years after the fiscal
year end date as of which the amount to be waived or reimbursed was determined
and the waiver or reimbursement occurred.